?重組腫瘤抑制基因P53/野生型P53蛋白
| 英文名稱 | Recombinant human P53 protein, C-His |
| 中文名稱 | 重組腫瘤抑制基因P53/野生型P53蛋白 |
| 別????名 | Widespread p53; Wtp53; Antigen NY-CO-13; Cellular tumor antigen p53; Cys 51 Stop; HGNC11998; LFS1; p53; p53 Cellular Tumor Antigen; p53 Tumor Suppressor; Phosphoprotein p53; TP53; Transformation related protein 53; TRP53; Tumor protein p53; Tumour Protein p53; P53_HUMAN; TP53; Recombinant human P53 protein, C-His??重組P53蛋白 |
| 理論分子量 | 43kDa |
| 檢測分子量 | 57 kDa |
| 性????狀 | Lyophilized or Liquid |
| 物????種 | Human |
| 序????列 | 1-393/393 |
| 純????度 | >95% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內毒素 | Not analyzed |
| 表達系統 | E.coli |
| 活性 | Not tested |
| 標簽 | C-His |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 | This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons (PMIDs: 12032546, 20937277). [provided by RefSeq, Feb 2013]. ? |
| 產品圖片 |
 The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
 The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
|